JP2020504130A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504130A5 JP2020504130A5 JP2019536487A JP2019536487A JP2020504130A5 JP 2020504130 A5 JP2020504130 A5 JP 2020504130A5 JP 2019536487 A JP2019536487 A JP 2019536487A JP 2019536487 A JP2019536487 A JP 2019536487A JP 2020504130 A5 JP2020504130 A5 JP 2020504130A5
- Authority
- JP
- Japan
- Prior art keywords
- nanoconjugate
- cancer
- dtdtpa
- thioctic acid
- doxorubicin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762444114P | 2017-01-09 | 2017-01-09 | |
| US62/444,114 | 2017-01-09 | ||
| PCT/US2018/012882 WO2018129501A1 (en) | 2017-01-09 | 2018-01-09 | Targeted doxorubicin-gold nanoconjugates for tumor therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504130A JP2020504130A (ja) | 2020-02-06 |
| JP2020504130A5 true JP2020504130A5 (enExample) | 2021-02-04 |
| JP7017258B2 JP7017258B2 (ja) | 2022-02-08 |
Family
ID=62791162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536487A Expired - Fee Related JP7017258B2 (ja) | 2017-01-09 | 2018-01-09 | 腫瘍治療のための標的化されたドキソルビシン－金ナノコンジュゲート |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210015944A1 (enExample) |
| EP (1) | EP3568694B1 (enExample) |
| JP (1) | JP7017258B2 (enExample) |
| KR (1) | KR102568577B1 (enExample) |
| CN (1) | CN110178028B (enExample) |
| AU (1) | AU2018205349B2 (enExample) |
| BR (1) | BR112019013469A2 (enExample) |
| CA (1) | CA3048908A1 (enExample) |
| ES (1) | ES2912286T3 (enExample) |
| MX (1) | MX2019008233A (enExample) |
| WO (1) | WO2018129501A1 (enExample) |
| ZA (1) | ZA201904736B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101887421B1 (ko) * | 2016-09-20 | 2018-08-13 | 김문혜 | 체인 구동형 유기질비료 발효 건조장치 |
| CN113797353B (zh) * | 2020-06-12 | 2023-10-20 | 南京工业大学 | 一种放化疗联合治疗试剂及其制备方法 |
| CN112494660B (zh) * | 2020-12-22 | 2023-11-21 | 上海交通大学 | 纳米靶向药物的制备方法及在治疗胃癌中的应用 |
| US12485484B2 (en) | 2022-05-17 | 2025-12-02 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Seedless synthesis of anisotropic gold nanoflowers with cellular control and drug delivery applications |
| WO2023242766A1 (en) | 2022-06-15 | 2023-12-21 | Alembic Pharmaceuticals Limited | Gold nanoconjugates |
| CN120713846A (zh) * | 2025-07-14 | 2025-09-30 | 湖南省妇幼保健院 | 基于铜离子和多柔比星的纳米级配位聚合物NP@DoxCu及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101563360A (zh) * | 2006-10-20 | 2009-10-21 | 益普生制药两合公司 | 肽-细胞毒性缀合物 |
| US20100021471A1 (en) * | 2008-07-25 | 2010-01-28 | Brookhaven Science Associates, Llc | Carbon nanotube-based drug delivery systems and methods of making same |
| WO2010014812A2 (en) * | 2008-07-30 | 2010-02-04 | The Research Foundation Of State University Of New York | Peptide compositions and methods of use |
| KR101196667B1 (ko) * | 2010-04-15 | 2012-11-02 | 포항공과대학교 산학협력단 | 피에이치 민감성 금속 나노 입자를 이용한 항암제 전달 시스템 |
| US9605304B2 (en) * | 2011-07-20 | 2017-03-28 | The Hong Kong Polytechnic University | Ultra-stable oligonucleotide-gold and-silver nanoparticle conjugates and method of their preparation |
| JP6693868B2 (ja) * | 2013-02-19 | 2020-05-13 | ナショナル ヘルス リサーチ インスティテューツＮａｔｉｏｎａｌ Ｈｅａｌｔｈ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅｓ | 抗癌化学療法剤用のケージ化された白金ナノクラスタ |
| DK3089997T3 (da) * | 2013-12-30 | 2020-06-15 | Univ Missouri | Au-multikomponent-nanomaterialer og fremgangsmåder til syntese |
-
2018
- 2018-01-09 EP EP18736294.2A patent/EP3568694B1/en active Active
- 2018-01-09 BR BR112019013469-7A patent/BR112019013469A2/pt not_active Application Discontinuation
- 2018-01-09 MX MX2019008233A patent/MX2019008233A/es unknown
- 2018-01-09 AU AU2018205349A patent/AU2018205349B2/en not_active Ceased
- 2018-01-09 CA CA3048908A patent/CA3048908A1/en active Pending
- 2018-01-09 JP JP2019536487A patent/JP7017258B2/ja not_active Expired - Fee Related
- 2018-01-09 CN CN201880006184.9A patent/CN110178028B/zh not_active Expired - Fee Related
- 2018-01-09 ES ES18736294T patent/ES2912286T3/es active Active
- 2018-01-09 WO PCT/US2018/012882 patent/WO2018129501A1/en not_active Ceased
- 2018-01-09 KR KR1020197019628A patent/KR102568577B1/ko active Active
- 2018-01-09 US US16/478,999 patent/US20210015944A1/en not_active Abandoned
-
2019
- 2019-07-18 ZA ZA2019/04736A patent/ZA201904736B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020504130A5 (enExample) | ||
| Fabbro et al. | Targeting carbon nanotubes against cancer | |
| JP2011500601A5 (enExample) | ||
| ES2826398T3 (es) | Enlazadores-fármacos pegilados para una mejor farmacocinética de los conjugados ligando-fármaco | |
| CN102686243B (zh) | 用于抗癌剂递送的聚合物系统 | |
| JP2017521486A5 (enExample) | ||
| ES2697348T3 (es) | Péptidos y conjugados de principio activo-péptido para direccionamiento renal | |
| KR101705077B1 (ko) | Ｈｐｍａ-도세탁셀 또는 젬시타빈 컨쥬게이트 및 이의 용도 | |
| CN110178028B (zh) | 用于肿瘤治疗的靶向阿霉素-金纳米缀合物 | |
| JP2018509394A5 (enExample) | ||
| HRP20151172T1 (hr) | Sastavi i postupci za dijagnosticiranje i lijeäśenje raka | |
| ME02919B (me) | Konjugati humanog antitijela sa lijekom protiv tkivnog faktora | |
| JP2017537893A5 (enExample) | ||
| CN108578708A (zh) | 一种双靶向多肽-药物偶联物及其制备方法与抗肿瘤应用 | |
| JP2012505922A5 (enExample) | ||
| EP3089997B1 (en) | Au multicomponent nanomaterials and synthesis methods | |
| Rizvi et al. | Engineering peptide drug therapeutics through chemical conjugation and implication in clinics | |
| JP2018507689A5 (enExample) | ||
| JPWO2020037434A5 (enExample) | ||
| Alcantara et al. | A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy | |
| Wang et al. | New trends and future developments of platinum‐based antitumor drugs | |
| DE50212918D1 (de) | Polypeptid, dessen konjugat doxorubicin enthält, uetzung | |
| CN116917278A (zh) | 用于靶向递送应用的二价成纤维细胞活化蛋白配体 | |
| US20200181185A1 (en) | Payload and linker designs for platinum-acridine anticancer agents and methods thereof | |
| WO2019244954A1 (ja) | ホウ素中性子捕捉療法用の腫瘍組織を短時間で選択的ないし局所的に標的化できる集積性ボロン１０薬剤 |